TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects
Michele Sommariva(University of Milan), Andrea Balsari(University of Milan), Graziella Pratesi, Loris De Cecco(Fondazione IRCCS Istituto Nazionale dei Tumori), Valentina Uva(University of Milan), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Michelandrea De Cesare(Fondazione IRCCS Istituto Nazionale dei Tumori), Elda Tagliabue(Fondazione IRCCS Istituto Nazionale dei Tumori), Domenico Delia(IFOM), Lucia Sfondrini(Fondazione IRCCS Istituto Nazionale dei Tumori), Sylvie Ménard(Fondazione IRCCS Istituto Nazionale dei Tumori), Cecilia Melani(ASL Roma)
Cited by 39
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
|Cellular and Molecular Life Sciences|2002|274